Literature DB >> 19385290

Transfusion, not just injury severity, leads to posttrauma infection: a matched cohort study.

Javid Sadjadi1, Elizabeth L Cureton, Patrick Twomey, Gregory P Victorino.   

Abstract

Blood transfusion has been associated with infection; however, the collinearity of injury severity has not been clearly addressed to show a direct relationship. Using more rigorous analysis, we aimed to untangle the effect of injury severity from transfusion leading to sepsis. We hypothesized that blood transfusion independently increases infection in massively transfused versus nontransfused patients with matched Injury Severity Scores (ISSs). We performed a matched cohort study measuring infection rates in trauma patients receiving massive transfusion. Control subjects were contemporaneous patients with matched ISS receiving no blood. Infection was defined as intraperitoneal or intrathoracic abscesses, pneumonia, urinary tract infection, or bacteremia. Multivariate logistic and univariate analysis was completed. Infection rate was 61 per cent in 44 transfused patients versus 20 per cent in 44 control subjects (P = 0.001). Odds of infection were eightfold greater in transfused patients (OR, 7.97; 95% CI, 2.3 to 27.5; P < 0.001) independent of ISS, Glasgow Coma Scale, mechanism, and age. Infection was most associated with transfusion of packed red blood cells (PRBCs), although transfusion of other blood products had strong collinearity with PRBCs. Transfused patients had eight times the risk of infection independent of ISS; this appears to be the result of PRBC transfusion. Modifying the ratio of components in transfusion protocols favoring plasma may cause less infection after injury.

Entities:  

Mesh:

Year:  2009        PMID: 19385290

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  7 in total

1.  Immunosuppressive effects of red blood cells on monocytes are related to both storage time and storage solution.

Authors:  Jennifer Muszynski; Jyotsna Nateri; Kathleen Nicol; Kristin Greathouse; Lisa Hanson; Mark Hall
Journal:  Transfusion       Date:  2011-10-07       Impact factor: 3.157

2.  Supernatants and lipids from stored red blood cells activate pulmonary microvascular endothelium through the BLT2 receptor and protein kinase C activation.

Authors:  Christopher C Silliman; Marguerite R Kelher; Samina Y Khan; F Bernadette West; Nathan J D McLaughlin; David J Elzi; Kelly England; Jason Bjornsen; Susan A Kuldanek; Anirban Banerjee
Journal:  Transfusion       Date:  2017-09-06       Impact factor: 3.157

3.  Effect of fresh frozen plasma on the in vitro activation of U937 monocytes: a potential role for the age of blood donors and their underlying cytokine profile.

Authors:  Mariana Patlán; Fausto Sánchez-Muñoz; Luis M Amezcua-Guerra; Adriana Granados; Araceli Páez; Felipe Massó; Ana M Mejía; Angeles Soster; Rafael Bojalil; Lenin Pavón; Luis A Jiménez-Zamudio; Ricardo Márquez-Velasco
Journal:  Biol Res       Date:  2017-12-21       Impact factor: 5.612

4.  Risk Factors of Bacteremia following Multiple Traumas.

Authors:  Hak-Jae Lee; Eol Choi; Nak-Joon Choi; Hyun-Woo Sun; Jae-Suk Lee; Jeong-Woo Lee; Tae-Yoon Kim; Yoon-Joong Jung; Suk-Kyung Hong
Journal:  Emerg Med Int       Date:  2020-04-06       Impact factor: 1.112

Review 5.  [Anemia and transfusion therapy: an update].

Authors:  Z Madrazo-González; A García-Barrasa; L Rodríguez-Lorenzo; A Rafecas-Renau; G Alonso-Fernández
Journal:  Med Intensiva       Date:  2010-05-18       Impact factor: 2.491

6.  Post-Traumatic Sepsis Is Associated with Increased C5a and Decreased TAFI Levels.

Authors:  Jan Tilmann Vollrath; Ingo Marzi; Anna Herminghaus; Thomas Lustenberger; Borna Relja
Journal:  J Clin Med       Date:  2020-04-24       Impact factor: 4.241

7.  Attenuation of MODS-related and ARDS-related mortality makes infectious complications a remaining challenge in the severely injured.

Authors:  Karlijn J P van Wessem; Falco Hietbrink; Luke P H Leenen
Journal:  Trauma Surg Acute Care Open       Date:  2020-02-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.